Bifidobacterium longum subsp. infantis M-63: shaping early-life gut microbiota and immunity in healthy full-term infants

Akari Hiraku, researcher at Innovative Research Institute, Morinaga Milk Industry Co., presented clinical data on Bifidobacterium longum subsp. infantis M-63, a probiotic strain with a remarkable capacity to utilize HMOs.

Early-life microbiota and diet protect fertility in mice

Dietary fiber during early life protects fertility by supporting healthy gut microbes and preventing ovarian damage caused by high-fat diets.

Gut microbes may be linked to heart damage in chronic kidney disease

Gut microbes could be a target for preventing kidney disease-related heart failure.

IPA Europe brings probiotic economy to the fore at Brussels policy summit

2 December event in Brussels will unveil new socio-economic analysis on how clearer EU rules for probiotics could cut healthcare costs, drive innovation and strengthen the single market.

The story of three new probiotics: from infancy to discovery

Bifidobacterium breve 2TA, Lacticaseibacillus rhamnosus L13B, and Lactobacillus gasseri L6 are not just bacteria: they are witnesses to the intimate, ancestral dialogue between mothers, infants, and microbes.

Faecalibacterium prausnitzii: a microbiome-based candidate for IBD, C. diff and cancer

Philippe Langella, Research director at INRAE, talks about how F. prausnitzii could be a beneficial commensal.

Gut bacteria and metabolites may be drivers of chronic pain in sickle cell disease

Restoring beneficial bacteria could lead to new treatments for chronic pain in people with sickle cell disease.

Maternal microbes may trigger preterm birth by altering pregnancy hormones

Gut microbes can interact with genetics and hormone metabolism to influence pregnancy outcomes.

Standardizing evidence on probiotics in acute gastroenteritis: why guidelines diverge and clinicians are confused

Yvan Vandenplas, Head of the Pediatric Hospital at the University Hospital Brussels, uses the example of probiotics in acute gastroenteritis to highlight how heterogeneous methodologies in evidence synthesis can lead…

Gut-brain connection may be a predictor of Alzheimer’s and Parkinson’s risk

Combining data about gut-brain–related disorders with genetic and other information provides a powerful approach for predicting Alzheimer’s and Parkinson’s disease.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top